APCS and early-onset autosomal dominant Alzheimer disease: The high-affinity ligand CPHPC was later produced in a medicinal chemistry programme following an initial high-throughput screen for inhibitors of the binding of human SAP to amyloid fibrils formed from the Alzheimer’s disease Aβ1–42 peptide (Pepys et al., 2002 ▶).